Valuation Joinn Laboratories(China)Co.,Ltd. Hong Kong S.E.
Stocks
6127
CNE100004BP3
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.46 HKD | -2.32% |
|
+2.95% | +18.74% |
Company Valuation: Joinn Laboratories(China)Co.,Ltd.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 40,246 | 29,328 | 16,313 | 11,374 | 23,924 | 30,631 | - | - |
| Change | - | -27.13% | -44.38% | -30.28% | 110.35% | 28.03% | - | - |
| Enterprise Value (EV) 1 | 36,161 | 26,442 | 13,478 | 10,430 | 23,032 | 28,745 | 28,509 | 28,069 |
| Change | - | -26.88% | -49.03% | -22.61% | 120.83% | 24.8% | -0.82% | -1.54% |
| P/E | 76.4x | 29.2x | 44.7x | 166x | 87.5x | 76.4x | 76.1x | 45.9x |
| PBR | 6.16x | 3.82x | 2.15x | 1.54x | 3.15x | 4.11x | 4.01x | 3.75x |
| PEG | - | 0.3x | -0.7x | -2x | 0x | 1.3x | 194.85x | 0.7x |
| Capitalization / Revenue | 26.5x | 12.9x | 6.86x | 5.64x | 14.4x | 16.6x | 14.5x | 12.2x |
| EV / Revenue | 23.8x | 11.7x | 5.67x | 5.17x | 13.9x | 15.6x | 13.5x | 11.1x |
| EV / EBITDA | 50x | 19.8x | 21.5x | 48.8x | 46x | 180x | 74.1x | 36.6x |
| EV / EBIT | 56.2x | 21.6x | 26.6x | 152x | 68x | 60.2x | 105x | 45.1x |
| EV / FCF | 80.6x | 38x | 31.3x | 153x | 76.5x | 77.9x | 125x | 129x |
| FCF Yield | 1.24% | 2.63% | 3.19% | 0.65% | 1.31% | 1.28% | 0.8% | 0.78% |
| Dividend per Share 2 | 0.1837 | 0.2857 | 0.16 | 0.03 | 0.12 | 0.0978 | 0.1187 | 0.385 |
| Rate of return | 0.31% | 0.68% | 0.67% | 0.18% | 0.34% | 0.2% | 0.24% | 0.79% |
| EPS 2 | 0.7704 | 1.429 | 0.53 | 0.1 | 0.4 | 0.635 | 0.6375 | 1.056 |
| Distribution rate | 23.8% | 20% | 30.2% | 30% | 30% | 15.4% | 18.6% | 36.5% |
| Net sales 1 | 1,517 | 2,268 | 2,376 | 2,018 | 1,658 | 1,848 | 2,113 | 2,518 |
| EBITDA 1 | 723.1 | 1,333 | 626.1 | 213.9 | 500.7 | 160 | 384.5 | 766.5 |
| EBIT 1 | 643 | 1,226 | 507.1 | 68.81 | 338.9 | 477.2 | 270.9 | 622.6 |
| Net income 1 | 557 | 1,074 | 397 | 74.08 | 297.8 | 491.8 | 380.9 | 930.8 |
| Net Debt 1 | -4,085 | -2,886 | -2,835 | -943.6 | -891.7 | -1,886 | -2,122 | -2,562 |
| Reference price 2 | 58.89 | 41.72 | 23.71 | 16.63 | 35.01 | 48.49 | 48.49 | 48.49 |
| Nbr of stocks (in thousands) | 747,243 | 749,950 | 746,974 | 733,989 | 733,375 | 733,375 | - | - |
| Announcement Date | 2/24/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/30/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 32.08x | 5.72x | 17.39x | 1.03% | 46.35B | ||
| -23.56x | 353.6x | -21.6x | -.--% | 40.13B | ||
| 49.04x | 4.97x | 31.86x | -.--% | 36.33B | ||
| 25.23x | 2.79x | 12.07x | -.--% | 34.6B | ||
| 26.59x | 7.81x | 19.59x | 0.43% | 26.77B | ||
| 34.86x | 5.67x | 26.04x | -.--% | 16.91B | ||
| 22.54x | 1.98x | 8.69x | 1.17% | 13.05B | ||
| 24.07x | 1.92x | 11.6x | -.--% | 13.05B | ||
| Average | 23.86x | 48.06x | 13.21x | 0.33% | 28.4B | |
| Weighted average by Cap. | 22.47x | 66.41x | 12.08x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- 603127 Stock
- 6127 Stock
- Valuation Joinn Laboratories(China)Co.,Ltd.
Select your edition
All financial news and data tailored to specific country editions
















